apoA-V Antibody (1F1E8) is a mouse monoclonal IgG1 antibody that detects apolipoprotein A-V in human samples through western blotting (WB). ApoA-V is a 366 amino acid protein encoded by the human apoA-V gene, and plays a crucial role in lipid metabolism, particularly in the regulation of plasma triglyceride levels. apoA-V is primarily synthesized in the liver and secreted into the bloodstream, where apoA-V interacts with various lipoproteins, influencing their metabolism and clearance. Notably, apoA-V has been shown to modulate the activity of lipoprotein lipase, an enzyme essential for the hydrolysis of triglycerides in lipoproteins, thereby impacting overall lipid homeostasis. The importance of apoA-V in triglyceride metabolism makes apoA-V a significant biomarker for cardiovascular diseases, as elevated triglyceride levels are associated with an increased risk of atherosclerosis and other cardiovascular conditions. With specificity for human apolipoprotein A-V, anti-apoA-V antibody (1F1E8) is an invaluable tool for researchers investigating lipid metabolism and related disorders.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
apoA-V Antibody (1F1E8) | sc-65992 | 200 µg/ml | $316.00 | |||
apoA-V Antibody (1F1E8): m-IgG Fc BP-HRP Bundle | sc-539203 | 200 µg Ab; 10 µg BP | $354.00 |